NCT03448367 - FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatric Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 27, 2018

Primary Completion Date

July 17, 2020

Study Completion Date

October 13, 2020

Conditions

Diabetes Mellitus

Interventions

DEVICE

FreeStyle Libre Flash Glucose Monitoring System

Subjects will utilize capillary SMBG for managing diabetes for 6 months (control phase) followed by diabetes management using FreeStyle Libre for 6 months (intervention phase).

Trial Locations (4)

80045

Barbara Davis Center for Diabetes, Aurora

83404

Rocky Mountain Diabetes & Osteoporosis Center, Idaho Falls

87109

Albuquerque Neuroscience Inc., Albuquerque

93105

Sansum Diabetes Research Institute, Santa Barbara